Acceptability of Less Harmful Alternatives to Cigarettes

• Status: Completed
• Trial end date: 2011-11-01
• Target enrollment: 0
• Participant gender: All

Summary

RATIONALE: A study that evaluates participants' beliefs about smokeless tobacco products and nicotine replacement therapy may be useful in helping smokers stop smoking.

PURPOSE: This clinical trial is studying the acceptability of less harmful alternatives to cigarettes.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Roswell Park Cancer Institute
• Collaborator: National Cancer Institute (NCI)
• Treatments: Nicotine

Criteria

DISEASE CHARACTERISTICS:

• Currently smokes ≥ 10 cigarettes per day

• Not planning to quit smoking in the next 30 days and has not tried to quit in the past 30 days

• Medically eligible to receive nicotine-replacement products, based on the NYS Smokers Quitline eligibility criteria

PATIENT CHARACTERISTICS:

• Not pregnant or nursing

• Able to read and speak English

• In good general health

• No history of heart attack or stroke in the past 2 weeks

• No history of chest pains in the past month

• No report of physician-diagnosed arrhythmia/irregular heartbeat or use of pacemaker

• No report of physician-diagnosed heart disease/coronary artery disease, uncontrolled hypertension, stomach ulcer, diabetes, depression, or asthma

PRIOR CONCURRENT THERAPY:

• No other concurrent tobacco products or nicotine medications

• No concurrent Zyban, Bupropion, Wellbutrin, Chantix, or other smoking cessation medication